• 26TH JANUARY 2023

    MHRA Drug Safety Update January 2023

    A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 6 January 2023) has been published and includes articles on: Xaqua (metolazone) 5mg tablets: exercise caution when switching patients between metolazone preparations Topical testosterone (Testogel): risk of harm to children following accidental exposure Electronic Prescribing and Medicines Administration Systems: report

    Read more
    • 25TH JANUARY 2023

    Company Led Medicines Recall: Clopidogrel Oral Solution 75mg in 5ml Prulab Pharma Ltd (Unlicensed medicine)

    CLMR number: CLMR (23)A/02 Date issued: 25th January 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company-led medicines recall for: Clopidogrel Oral Solution 75mg in 5ml Prulab Pharma Ltd (Unlicensed medicine). Clopidogrel Oral Solution 75mg in 5ml [unlicensed medicine] Batch number Expiry Date Pack Size First Distributed D2207227403B 21 July 2023

    Read more
    • 25TH JANUARY 2023

    Two new SSPs issued for Estradot® 50mcg and 100mcg patches

    In response to a significant ongoing disruption to the supply of Estradot® 50mcg and 100mcg patches, two new Serious Shortage Protocols (SSPs) have been issued by the Department of Health and Social Care (DHSC). Effective 25 January 2023, SSP049 and SSP049 provides for the following: SSP048 – for every Estradot® 50mcg  patch originally prescribed, one Evorel®

    Read more
    • 24TH JANUARY 2023

    Register for our Data Security and Protection Toolkit (2023) Workshop

    PSNC will be holding a webinar on Thursday 23rd February at 7pm to help community pharmacy contractors to complete the Data Security and Protection Toolkit for 2022/23. We worked in collaboration with NHS Digital on the new requirements and made improvements to this year’s Toolkit. We encourage contractors to register and join us in this webinar as we

    Read more
    • 23RD JANUARY 2023

    MPs call for urgent action to protect the future of pharmacy

    A report published by the All-Party Parliamentary Group (APPG) on Pharmacy today calls for “urgent action” to relieve the significant funding and workforce pressures on community pharmacy and to deliver on the full potential of pharmacy teams. The Future of Pharmacy: Manifesto report calls for a new “strategic vision” for pharmacies and highlights the opportunity

    Read more
    • 23RD JANUARY 2023

    Medicine Supply Notification: Senokot® syrup and Senokot® 12 Years Plus syrup (both containing 7.5mg/5ml sennosides)

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Senokot® syrup and Senokot® 12 Years Plus syrup (both containing 7.5mg/5ml sennosides) MSN/2023/004 Tier 2 – medium impact Date of issue 23rd January 2023 Senokot® syrup 7.5mg/5ml syrup is out of stock until w/c 6th March 2023. Senokot® syrup 12 Years

    Read more
    • 23RD JANUARY 2023

    DHSC to remove Transitional Payments from February

    The Department of Health and Social Care (DHSC) has decided to reduce the Transitional Payment to zero from February 2023. PSNC’s Negotiating Team refused to accept this on the grounds that any reductions in payments at this point will be impossible for community pharmacy contractors to manage financially. We are also continuing to be clear

    Read more
    • 20TH JANUARY 2023

    January 2023 Price Concessions 2nd Update

    The Department of Health and Social Care (DHSC) has today (20/01/2023) granted the following list of price concessions for January 2023.   Drug Pack Size Price concession Carbocisteine 250mg/5ml oral solution 300 £8.50 Cinnarizine 15mg tablets 84 £7.51 Clarithromycin 500mg tablets 14 £10.48 Co-amoxiclav 250mg/125mg tablets 21 £3.54 Colecalciferol 1,000unit capsules 30 £8.40 Erythromycin 250mg

    Read more
    • 19TH JANUARY 2023

    PQS: More than 15,000 patients referred as part of NSAID audits

    An evaluation of the 2018/19 and 2019/20 non-steroidal anti-inflammatory drugs (NSAID) Pharmacy Quality Scheme (PQS) audits has been published in the British Medical Journal Open Quality. The evaluation shows that community pharmacy teams spoke to over 165,000 patients during the two audit periods and referred more than 15,000 patients at risk of preventable harm from

    Read more
    • 19TH JANUARY 2023

    Class 3 Medicines Recall: Lacidipine 4 mg Film-Coated Tablets (Dr Reddy’s)

    Class 3 Medicines recall: Lacidipine 4 mg Film-Coated Tablets (Dr Reddy’s Laboratories (UK) Ltd) Drug alert number: EL (23)A/03 Date issued: 19 January 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Lacidipine 4 mg Film-Coated Tablets (Dr Reddy’s Laboratories (UK) Ltd), PL 08553/0503 Brief description of

    Read more